Hims & Hers shares tumble
Hims & Hers Health Inc.’s stock plunged last week when the Food and Drug Administration said that there was no longer a ...
Shares of Hims & Hers Health plunged Friday after the Food & Drug Administration said a shortage of the active ingredient in ...
The ruling shows Novo Nordisk’s confidence that the supply of semaglutide will be stable for now.
Shares of Hims & Hers Health dropped 22% in premarket trading as efforts by ... a version of the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. The company ...
Hims & Hers Health shares tumbled despite the telehealth provider beating fourth-quarter expectations and offering ...
Shares of Hims & Hers Health ( HIMS -25.79%) are falling on Friday. The company's stock lost 23.2% as of 1 p.m. ET and lost ...
Hims & Hers Health (HIMS) has seen its shares decline over 17% in the past week since the U.S. Food and Drug Administration (FDA) announced ...
Online health and wellness company Hims & Hers reported fourth-quarter earnings that beat Wall Street analysts' expectations ...
Shares of direct-to-consumer telehealth platform Hims & Hers Health (NYSE: HIMS) have become a runaway freight train. The ...
Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback